BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32418983)

  • 1. Prognostic Value of Neutrophil-Lymphocyte Ratio in Cardiogenic Shock: A Cohort Study.
    Peng Y; Wang J; Xiang H; Weng Y; Rong F; Xue Y; Ji K
    Med Sci Monit; 2020 May; 26():e922167. PubMed ID: 32418983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The neutrophil-lymphocyte ratio: A promising predictor of mortality in coronary care unit patients - A cohort study.
    Sun H; Que J; Peng Y; Ye H; Xiang H; Han Y; Wang J; Ji K
    Int Immunopharmacol; 2019 Sep; 74():105692. PubMed ID: 31228818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-institutional analysis of neutrophil-to-lymphocyte ratio (NLR) in patients with severe hemorrhage: A new mortality predictor value.
    Duchesne JC; Tatum D; Jones G; Davis B; Robledo R; DeMoya M; O'Keeffe T; Ferrada P; Jacome T; Schroll R; Wlodarczyk J; Prakash P; Smith B; Inaba K; Khor D; Duke M; Khan M
    J Trauma Acute Care Surg; 2017 Nov; 83(5):888-893. PubMed ID: 28837540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study.
    Fan Z; Li Y; Ji H; Jian X
    BMJ Open; 2018 Oct; 8(10):e023459. PubMed ID: 30341133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Significance of Preoperative Neutrophil-to-Lymphocyte Ratio in Surgically Resectable Pancreatic Neuroendocrine Tumors.
    Zhou B; Zhan C; Wu J; Liu J; Zhou J; Zheng S
    Med Sci Monit; 2017 Nov; 23():5574-5588. PubMed ID: 29168979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-lymphocyte ratio as a novel predictor of survival in chronic hemodialysis patients.
    Ouellet G; Malhotra R; Penne EL; Usvya L; Levin NW; Kotanko P
    Clin Nephrol; 2016 Apr; 85(4):191-8. PubMed ID: 26951970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Neutrophil-to-Lymphocyte Ratio at the Time of Admission: A New Prognostic Indicator for Hospital Mortality of Trauma Patients.
    Fouladseresht H; Bolandparvaz S; Abbasi HR; Abdolrahimzadeh Fard H; Paydar S
    Iran J Allergy Asthma Immunol; 2021 Jan; 20(1):33-45. PubMed ID: 33639631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of neutrophil-lymphocyte ratio in critically ill patients with cancer: a propensity score matching study.
    Chen ZQ; Yu XS; Mao LJ; Zheng R; Xue LL; Shu J; Luo ZW; Pan JY
    Clin Transl Oncol; 2021 Jan; 23(1):139-147. PubMed ID: 32472452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neutrophil-to-lymphocyte ratio on admission is a good predictor for all-cause mortality in hypertensive patients over 80 years of age.
    Sun X; Luo L; Zhao X; Ye P; Du R
    BMC Cardiovasc Disord; 2017 Jun; 17(1):167. PubMed ID: 28646855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutrophil-to-lymphocyte ratio predicts long-term all-cause mortality in patients with chronic kidney disease stage 5.
    Woziwodzka K; Dziewierz A; Pawica M; Panek A; Krzanowski M; Gołasa P; Latacz P; Burkat M; Kuźniewski M; Krzanowska K
    Folia Med Cracov; 2019; 59(4):55-70. PubMed ID: 31904750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the prognostic value of the neutrophil-to-lymphocyte ratio in cancer.
    Howard R; Kanetsky PA; Egan KM
    Sci Rep; 2019 Dec; 9(1):19673. PubMed ID: 31873162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil-Lymphocyte Ratio: Prognostic Impact in Heart Surgery. Early Outcomes and Late Survival.
    Silberman S; Abu-Yunis U; Tauber R; Shavit L; Grenader T; Fink D; Bitran D; Merin O
    Ann Thorac Surg; 2018 Feb; 105(2):581-586. PubMed ID: 29132702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy.
    Templeton AJ; Knox JJ; Lin X; Simantov R; Xie W; Lawrence N; Broom R; Fay AP; Rini B; Donskov F; Bjarnason GA; Smoragiewicz M; Kollmannsberger C; Kanesvaran R; Alimohamed N; Hermanns T; Wells JC; Amir E; Choueiri TK; Heng DY
    Eur Urol; 2016 Aug; 70(2):358-64. PubMed ID: 26924770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil to lymphocyte ratio - A novel prognostic marker following spontaneous intracerebral haemorrhage.
    Menon G; Johnson SE; Hegde A; Rathod S; Nayak R; Nair R
    Clin Neurol Neurosurg; 2021 Jan; 200():106339. PubMed ID: 33183885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-lymphocyte ratio at diagnosis is an independent prognostic factor in patients with nodular sclerosis Hodgkin lymphoma: results of a large multicenter study involving 990 patients.
    Marcheselli R; Bari A; Tadmor T; Marcheselli L; Cox MC; Pozzi S; Ferrari A; Baldini L; Gobbi P; Aviv A; Pugliese G; Federico M; Polliack A; Sacchi S
    Hematol Oncol; 2017 Dec; 35(4):561-566. PubMed ID: 27791277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil-to-lymphocyte ratio is associated with 28-day mortality in patients with severe fever with thrombocytopenia syndrome.
    Liu Y; Ni J; Xiong Y; Wu C; He F
    BMC Infect Dis; 2022 Mar; 22(1):225. PubMed ID: 35249544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic value of pretreatment neutrophil-to-lymphocyte ratio (NLR) in locally advanced non-small cell lung cancer patients treated with thoracic radiation].
    Dong X; Zhou ZM; Bi N; Wang JB; Ran JT; Hui ZG; Liang J; Feng QF; Chen DF; Xiao ZF; Lyu JM; Wang XZ; Wang X; Zhang T; Deng L; Wang WQ; Wang LH
    Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):446-451. PubMed ID: 29936771
    [No Abstract]   [Full Text] [Related]  

  • 20. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
    Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
    J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.